Current Vascular Pharmacology

Papers
(The TQCC of Current Vascular Pharmacology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Cardiovascular Disease in Systemic Lupus Erythematosus: Recent Data on Epidemiology, Risk Factors and Prevention59
Herbal Medicine for Slowing Aging and Aging-associated Conditions: Efficacy, Mechanisms and Safety56
Uncaria rhynchophylla and its Major Constituents on Central Nervous System: A Review on Their Pharmacological Actions41
Primary Sjögren’s Syndrome and Cardiovascular Disease28
Lifestyle, Maternal Nutrition and Healthy Pregnancy24
Thromboprophylaxis in Patients with COVID-19: Systematic Review of National and International Clinical Guidance Reports22
Cardiovascular Complications of Sleep Disorders: A Better Night’s Sleep for a Healthier Heart / From Bench to Bedside22
Rhizoma Coptidis for Alzheimer’s Disease and Vascular Dementia: A Literature Review21
Effects of Maternal Obesity and Gestational Diabetes Mellitus on the Placenta: Current Knowledge and Targets for Therapeutic Interventions21
Endothelial Dysfunction and Inflammatory Markers of Vascular Disease20
Osteoprotegerin and Osteopontin Serum Levels are Associated with Vascular Function and Inflammation in Coronary Artery Disease Patients19
Cardiovascular Risk in Rheumatoid Arthritis and Mechanistic Links: From Pathophysiology to Treatment19
Uric Acid in Metabolic and Cerebrovascular Disorders: A Review16
LncRNA MALAT1 Enhances ox-LDL-Induced Autophagy through the SIRT1/MAPK/NF-κB Pathway in Macrophages15
Prevalence, Diagnosis, and Treatment with 3 Different Statins of Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis in Military Personnel. Do Genetics Play a Role?15
Effects of Maternal Obesity On Placental Phenotype15
Inflammatory Markers in Cardiovascular Disease; Lessons Learned and Future Perspectives15
Metabolic Adaptations to Pregnancy in Healthy and Gestational Diabetic Pregnancies: The Pancreas - Placenta Axis15
Pathophysiology of Thrombosis in Peripheral Artery Disease15
Vitamin D and Vascular Disease15
The Innate Immune System and Cardiovascular Disease in ESKD: Monocytes and Natural Killer Cells15
The Burden of Cardiovascular Disease Risk Factors in the Middle East: A Systematic Review and Meta-Analysis Focusing on Primary Prevention14
Pre- and Post-Conditioning of the Heart: An Overview of Cardioprotective Signaling Pathways14
Coronary Calcium Risk Score and Cardiovascular Risk13
Antipsychotic Drugs and Risk of Developing Venous Thromboembolism and Pulmonary Embolism: A Systematic Review and Meta-Analysis13
Antiplatelet Therapy in Acute Coronary Syndromes. Lights and Shadows of Platelet Function Tests to Guide the Best Therapeutic Approach13
New Insight into the Mechanisms of Ginkgo Biloba Extract in Vascular Aging Prevention12
Cardiovascular Consequences of Autoimmune Rheumatic Diseases12
PCSK9 Inhibitors and Ezetimibe Monotherapy in Patients Not Receiving Statins: A Meta-Analysis of Randomized Trials12
The Endothelial Glycocalyx as a Key Mediator of Albumin Handling and the Development of Diabetic Nephropathy11
Efficacy and Safety of Antiplatelet Therapies in Symptomatic Peripheral Artery Disease: A Systematic Review and Network Meta-Analysis11
Obesity and Gestational Diabetes in Pregnant Care and Clinical Practice10
Diabetes Mellitus, Arterial Stiffness and Cardiovascular Disease: Clinical Implications and the Influence of SGLT2i10
Pathogenic Mechanisms of Trimethylamine N-Oxide-induced Atherosclerosis and Cardiomyopathy9
New Insights into the Role of FGF-23 and Klotho in Cardiovascular Disease in Chronic Kidney Disease Patients9
Cardiovascular Disease in Patients with Chronic Obstructive Pulmonary Disease, Obstructive Sleep Apnoea Syndrome and Overlap Syndrome9
Non-Alcoholic Fatty Liver Disease and Vascular Disease9
Cardiovascular Effects of Biologic Disease-Modifying Anti-Rheumatic Drugs (DMARDs)9
Increased Fetal Cardiovascular Disease Risk: Potential Synergy Between Gestational Diabetes Mellitus and Maternal Hypercholesterolemia9
Erectile Dysfunction as a Cardiovascular Risk Factor: Time to Step Up?9
Cardiovascular Disease in Spondyloarthritides9
Compelling Indications Should be Listed for Individual Beta-Blockers (Due to Diversity), Not for the Whole Class8
The Myometrium in Pregnant Women with Obesity8
Inhibition of miR-223 Expression Using a Sponge Strategy Decreases Restenosis in Rat Injured Carotids8
Improving Adherence to Ticagrelor in Patients After Acute Coronary Syndrome: Results from the PROGRESS Trial8
Antithrombotic Therapy in Lower Extremity Artery Disease8
Non-alcoholic Fatty Liver Disease in Children7
Complementary and Alternative Medicine for the Treatment of Insomnia: An Overview of Scientific Evidence from 2008 to 20187
Could Antioxidant Supplementation Delay Progression of Cardiovascular Disease in End-Stage Renal Disease Patients?7
Pulse Wave Velocity Assessment for Cardiovascular Risk Prognostication in ESKD: Weighting Recent Evidence7
Outcomes of Anticoagulant Therapy with Low-Molecular-Weight Heparin (LMWH) and Warfarin for Thromboangiitis Obliterans (TAO)7
Vitamin K for the Treatment of Cardiovascular Disease in End-Stage Renal Disease Patients: Is there Hope?7
Hypertriglyceridemia: An Infrequent, Difficult-to-predict, Severe Metabolic and Vascular Problem Associated with Estrogen Administration7
Male Patients with Takayasu Arteritis and Coronary Artery Involvement are Prone to Have Serious Coronary Stenosis and High Mortality6
Cardiovascular Disease in the Systemic Vasculitides6
Investigating the Link between Psoriasis and Cardiovascular Disease: Current Evidence, Therapeutic Implications and Perspectives6
Advanced Glycation End Products in Chinese Medicine Mediated Aging Diseases: A Review6
Validation of Neuropad in the Assessment of Peripheral Diabetic Neuropathy in Patients with Diabetes Mellitus Versus the Michigan Neuropathy Screening Instrument, 10g Monofilament Application and Biot6
Contrast-induced Nephropathy in Non-cardiac Vascular Procedures, A Narrative Review: Part 16
Metabolic Complications and Kidney Transplantation: Focus on Glycaemia and Dyslipidaemia6
Features of a Balanced Healthy Diet with Cardiovascular and Other Benefits5
Effect of Mineralocorticoid Receptor Antagonists in Heart Failure with Preserved Ejection Fraction and with Reduced Ejection Fraction - A Narrative Review5
Herbal Medicine for Vascular Dementia: An Overview of Systematic Reviews5
Prognostic Significance of Relative Hyperglycemia after Percutaneous Coronary Intervention in Patients with and without Recognized Diabetes5
Endocrine Disorders and Peripheral Arterial Disease: A Series of Reviews5
Intermittent Fasting as Possible Treatment for Heart Failure5
Cardiovascular Disease in Antiphospholipid Syndrome5
STOPP/START Anti-aggregation and Anticoagulation Alerts in Atrial Fibrillation5
The Role of Inflammation as a Preponderant Risk Factor in Cardiovascular Diseases5
Stromal Cell-Derived Factor (SDF) 2 and the Endoplasmic Reticulum Stress Response of Trophoblast Cells in Gestational Diabetes Mellitus and In vitro Hyperglycaemic Condition5
Cardiovascular Disease in Juvenile Idiopathic Arthritis5
Effects of Gentiana lutea Root on Vascular Diseases5
COVID-19-associated Coagulopathy and Thromboembolism: Determination of Their Patterns and Risk Factors as Predictors of Mortality Among Severe COVID-19 Patients5
0.036438941955566